GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » Institutional Ownership

S Biomedics Co (XKRX:304360) Institutional Ownership : 0.50% (As of Jun. 08, 2024)


View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, S Biomedics Co's institutional ownership is 0.50%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, S Biomedics Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, S Biomedics Co's Float Percentage Of Total Shares Outstanding is 0.00%.


S Biomedics Co Institutional Ownership Historical Data

The historical data trend for S Biomedics Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co Institutional Ownership Chart

S Biomedics Co Historical Data

The historical data trend for S Biomedics Co can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.14 0.14 0.14 0.14 0.31 0.31 0.31 0.50 0.50 0.50

S Biomedics Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


S Biomedics Co (XKRX:304360) Business Description

Traded in Other Exchanges
N/A
Address
Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797
S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines